Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?

计划入组 183 人 · 首次发布于 2018 年 8 月 17 日

Hospital Medication Report

计划入组 280 人 · 首次发布于 2019 年 11 月 18 日

Comparison of Three Summary of Finding Tables to Improve Understanding in the Presentation of Systematic Review Results

计划入组 178 人 · 首次发布于 2016 年 6 月 27 日

EuPort

iloperidone depot

Allergovac depot

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

United States

Shift

PHARMED IMPORT & EXPORT PTE LTD

Singapore

ARCHIMED Acquires AI-Powered Antimicrobial Stewardship Company Arkstone Medical Group

AI-Driven Clinical Decision Support System Accelerates Bacteremia Treatment by 29 Hours in Groundbreaking Study

Psychedelic Therapy Clinical Trials Show CNS Focus and Rise in Phase II Studies